NPPA's preliminary analysis of common components used in knee implants shows profit margins for distributors and importers can be as high as 135%. After slashing the prices of cardiac stents by over 150 per cent the National Pharmaceutical Pricing Authority (NPPA) is all set to bring in price capping for orthopedic knee implants. The patient ends up paying six times the price of the orthopedic implants at the end. The total trade margin was found to be a whopping 313 per cent. Trade margins for total knee systemImporter: 76%Distributor and Hospital: 135%Total trade margin: 313%

Source: dna August 05, 2017 05:03 UTC